Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship.

Taruneshwar Jha, Keshav; Shome, Abhimannu; Chawla, Pooja A

Taruneshwar Jha, Keshav; Shome, Abhimannu; Chawla, Pooja A.

Afiliação

Taruneshwar Jha K; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India.
Shome A; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India.
Chahat; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India.
Chawla PA; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India. Electronic address: pvchawla@gmail.com.

Bioorg Chem ; 138: 106680, 2023 09.

Article em En | MEDLINE | ID: mdl-37336103

Assuntos

Neoplasias; Humanos; Nitrogênio; Fator A de Crescimento do Endotélio Vascular; Inibidores da Angiogênese/farmacologia; Inibidores de Proteínas Quinases/farmacologia; Inibidores de Proteínas Quinases/uso terapêutico; Inibidores de Proteínas Quinases/química; Neoplasias/tratamento farmacológico; Neoplasias/metabolismo; Receptores Proteína Tirosina Quinases/metabolismo

Palavras-chave

Cancer; Cell surface proteins; Heterocycles; Pro-angiogenic factors; Proliferation; Receptor tyrosine kinase; Structural activity relationship

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google